The U.S. Food and Drug Administration on Wednesday approved Johnson & Johnson's drug to treat a type of muscle-weakening ...

Health and Human Services employees were told in March to remove 'nicknames' from email systems and signatures to comply with ...

The FDA approved nipocalimab (Imaavy) injection to treat adults and children ages 12 and older with generalized myasthenia ...

British animal genetics company Genus on Wednesday said the U.S. Food and Drug Administration (FDA) approved its PRP gene ...

Zevaskyn is the first and only autologous cell-based gene therapy for recessive dystrophic epidermolysis bullosa ...

Hoagie rolls and sourdough and whole grain multigrain loaves from Upper Crust Bakery LP have all been recalled ...

AI is a transformational force in healthcare, but without cybersecurity as its foundation, it becomes a high-stakes gamble.

IMAAVY TM (nipocalimab-aahu) is a first-in-class FcRn (neonatal Fc receptor) inhibitor, designed to reduce the levels of ...

As food companies face pressure to eliminate artificial dyes, experts weigh in on the natural alternatives that could replace them.

Nipocalimab (Imaavy; Johnson & Johnson), an FcRn-blocking monoclonal antibody, was approved for patients 12 years and older ...

Pesticides, herbicides, insecticides, preservatives, toxic heavy metals like lead and mercury: Are micropoisons real—and dangerous? Experts reveal the truth.

The FDA has approved a monoclonal antibody to treat individuals aged 12 years and older with generalized myasthenia gravis ...